Sight Sciences, Inc.
Company Stats
- Market Cap
- $515.6M
- as of Sep 30, 2026
- Enterprise Value
- $464.0M
- Shares Outstanding
- 55.1M
- Free Float
- 43.9%
Income Statement
- Revenue
- $77.4M
- Operating Income
- -$37.1M
- Net Income
- -$38.4M
- EBITDA
- -$36.6M
- Revenue Growth, 3Y
- 2.7%
- FCF Margin, 3Y Avg
- -42.1%
- FCF Margin, Worst Year
- -59.2%
Cash Flow
- Free Cash Flow
- -$29.9M
- FCF Yield
- -5.8%
- Owner FCF Yield
- -8.3%
Balance Sheet
- Cash & Equivalents
- $92.0M
- Total Debt
- $40.3M
- Net Cash
- $51.7M
Returns & Capital
- SBC, 3Y Avg
- $14.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $77.4M | -$29.9M | -38.7% |
| FY2024 | $79.9M | -$22.7M | -28.5% |
| FY2023 | $81.1M | -$48.0M | -59.2% |
| FY2022 | $71.3M | -$76.9M | -107.9% |
| FY2021 | $49.0M | -$53.4M | -109.0% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 12, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
November 8, 2026
Weekly Earnings
Micro-Cap Earnings Roundup for Week of Nov. 2, 2026
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 6, 2026
Small-Cap Signal
Small Caps Leverage Pricing Power Amidst Input Volatility
Micro-Cap Earnings Roundup for Week of Nov. 2, 2026
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 6, 2026
Small-Cap Signal
Small Caps Leverage Pricing Power Amidst Input Volatility